Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Metabolic Monitoring Rates of Youth Treated with Second-Generation Antipsychotics in Usual Care: Results of a Large US National Commercial Health Plan.

Hayden JD, Horter L, Parsons T , III, Ruble M, Townsend S, Klein CC, Duran RP, Welge JA, Crystal S, Patel NC, Correll CU, DelBello MP.

J Child Adolesc Psychopharmacol. 2019 Dec 17. doi: 10.1089/cap.2019.0087. [Epub ahead of print]

PMID:
31851522
2.

Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study.

Dang-Tan T, Kamble PS, Meah Y, Gamble C, Ganguly R, Horter L.

Diabetes Ther. 2020 Jan;11(1):213-228. doi: 10.1007/s13300-019-00739-3. Epub 2019 Dec 9.

PMID:
31820328
3.

Blood lead and pediatric asthma.

Rabito FA, Horter L, Langlois EC, Carlson JC, White LE, Schwartz K, Osman P, Rice JC.

Epidemiology. 2013 May;24(3):474-6. doi: 10.1097/EDE.0b013e31828c7673. No abstract available.

PMID:
23549194
4.

Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.

Li L, Mahan CS, Palaci M, Horter L, Loeffelholz L, Johnson JL, Dietze R, Debanne SM, Joloba ML, Okwera A, Boom WH, Eisenach KD.

J Clin Microbiol. 2010 Jan;48(1):46-51. doi: 10.1128/JCM.01526-09. Epub 2009 Nov 18.

5.

Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

Johnson JL, Hadad DJ, Dietze R, Maciel EL, Sewali B, Gitta P, Okwera A, Mugerwa RD, Alcaneses MR, Quelapio MI, Tupasi TE, Horter L, Debanne SM, Eisenach KD, Boom WH.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):558-63. doi: 10.1164/rccm.200904-0536OC. Epub 2009 Jun 19.

6.

Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.

Palaci M, Dietze R, Hadad DJ, Ribeiro FK, Peres RL, Vinhas SA, Maciel EL, do Valle Dettoni V, Horter L, Boom WH, Johnson JL, Eisenach KD.

J Clin Microbiol. 2007 Dec;45(12):4064-6. Epub 2007 Oct 10.

7.

Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.

Kizza HM, Rodriguez B, Quinones-Mateu M, Mirza M, Aung H, Yen-Lieberman B, Starkey C, Horter L, Peters P, Baseke J, Johnson JL, Toossi Z.

Clin Diagn Lab Immunol. 2005 Nov;12(11):1298-304.

8.

Rifampicin-containing regimens for the treatment of latent tuberculosis infection also prevented diarrheal illnesses in HIV-infected Ugandan adults.

Johnson JL, Okwera A, Horter L, Whalen CC, Mugerwa RD; Uganda Case Western Reserve University Research Collaboration.

AIDS. 2004 Mar 5;18(4):706-8. No abstract available.

PMID:
15090784
9.

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.

Wallis RS, Kyambadde P, Johnson JL, Horter L, Kittle R, Pohle M, Ducar C, Millard M, Mayanja-Kizza H, Whalen C, Okwera A.

AIDS. 2004 Jan 23;18(2):257-64.

PMID:
15075543

Supplemental Content

Loading ...
Support Center